Zobrazeno 1 - 8
of 8
pro vyhledávání: '"F V Michelis"'
Autor:
Doris Howell, Vikas Gupta, Jeffrey H. Lipton, J C Victor, Naheed Alam, David Loach, Samantha J Mayo, Kelly A. Metcalfe, Hans A. Messner, Dennis Dong Hwan Kim, Laura McGillis, Sean B. Rourke, Jieun Uhm, F V Michelis, C Piescic, John Kuruvilla, Anna Lambie, D Breen
Publikováno v:
Bone Marrow Transplantation. 51:841-847
Although neurocognitive impairment has been established as a major issue among cancer survivors, the real-world consequences of this impairment are unclear. This study investigated the relationship between neurocognitive functioning and medication ma
Autor:
Auro Viswabandya, Uday Deotare, F V Michelis, Hans A. Messner, C Bourlon, Santhosh Thyagu, Deepali Kumar, S Alamoudi, D D-H Kim, Jeffrey H. Lipton
Publikováno v:
Bone Marrow Transplantation. 52:907-909
A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient
Autor:
Christopher Bredeson, Thomas Kiss, Mitchell Sabloff, Donna E. Hogge, Hyung-Ok Kim, Mats Brune, Stephen Couban, Kristjan Paulson, Eshetu G. Atenafu, Dawn Sheppard, J Slaby, W Rajkhan, F V Michelis, Donna A. Wall, Irwin Walker, Gizelle Popradi, Andrew Daly, Cynthia L. Toze, J Frazer, Hans A. Messner, Jürgen Finke, S Shivakumar, M Bakkar
Publikováno v:
Bone marrow transplantation. 51(7)
Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study
Autor:
Uday Deotare, F V Michelis, Hans A. Messner, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Wilson Lam, Auro Viswabandya, S Hussain
Publikováno v:
Bone Marrow Transplantation. 51:1385-1386
A 50-year-old woman was admitted to hospital due to fevers, dyspnea and hematuria. She was in second remission at 3 months post allogeneic stem cell transplant for AML from a matched unrelated donor. Her conditioning regimen consisted of fludarabine,
Autor:
Jeffrey H. Lipton, F V Michelis, Dennis Dong Hwan Kim, Santhosh Thyagu, Auro Viswabandya, David Loach, Hans A. Messner, Uday Deotare
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S365
Autor:
Auro Viswanandya, Santhosh Thyagu, Uday Deotare, F V Michelis, Dennis Dong Hwan Kim, Rehab M. Alblooshi, Hans A. Messner, Jeffrey H. Lipton
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S259
Autor:
F V Michelis, Eshetu G. Atenafu, Matthew D. Seftel, Naheed Alam, Jeffrey H. Lipton, Jieun Uhm, John Kuruvilla, Hans A. Messner, Anna Lambie, Laura McGillis, Vikas Gupta, Dennis Dong Hwan Kim, David Loach
Publikováno v:
Bone marrow transplantation. 50(7)
Secondary AML (sAML) has a poor prognosis with conventional chemotherapy alone. Allogeneic hematopoietic cell transplantation (HCT) is beneficial for high-risk AML. Data comparing outcomes of transplants for patients with de novo and sAML are limited
Autor:
Hans A. Messner, F V Michelis, Dennis Dong Hwan Kim, Nada Hamad, Matthew D. Seftel, John Kuruvilla, Jeffrey H. Lipton, Mohamed Shanavas, Jieun Uhm, Vikas Gupta
Publikováno v:
Bone marrow transplantation. 49(12)
Hemorrhagic cystitis (HC) is a common complication after allogeneic hematopoietic SCT (allo-HSCT). Several risk factors have been suggested including BU-containing myeloablative conditioning, unrelated donors and GVHD, but these have not been consist